- Types of drug interaction
- Interactions with illegal and recreational drugs
- Testing drug levels
- Summary: Testing drug levels
- How are drugs absorbed?
- Variability in protease inhibitor levels
- Measuring protease inhibitor levels
- Cmin and antiviral activity
- Gender differences in drug levels
- Testing levels of other drugs
- The link with adherence
- Access to drug monitoring in the United Kingdom
- Key research on testing for drug levels
Testing drug levels
- Summary: Testing drug levels
- How are drugs absorbed?
- Variability in protease inhibitor levels
- Measuring protease inhibitor levels
- Cmin and antiviral activity
- Gender differences in drug levels
- Testing levels of other drugs
- The link with adherence
- Access to drug monitoring in the United Kingdom
- Key research on testing for drug levels
latest aidsmap news
- Study explores verbal and non-verbal communication in unprotected sex between men
- IL-2 provides quick ‘AIDS rescue’, but effect does not always last
- Once-a-day etravirine should work as first-line treatment
- Second-line combinations fail twice as often as first-line ones in the first year
- If you can't switch, better to stay on failing treatment than stop it, studies show
- Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’
- One in five Kenyan patients suffers major interactions with HIV drugs
- HIV treatment safe and effective in South African patients with hepatitis B co-infection, but co-infection frequent
- South African resistance survey confirms that clade C is more likely to develop multi-drug resistance mutation
- Treatment breaks set for a come-back?